FMC has just submitted two new biological pesticide strains to the EPA for approval. These biologicals, which FMC anticipates will receive EPA approval in late 2020, will be used for seed treatment, in-furrow and transplant application to target diseases like Sudden Death Syndrome, Fusarium, Rhizoctonia and Phytophthora.
This unique combination of two bacilli strains offers a new option for growers to suppress some difficult to control and yield robbing diseases such as Sudden Death Syndrome (SDS) in soybeans as well as Fusarium, Rhizoctonia and Phytophthora. FMC is developing biological solutions which are unique to the marketplace and bring consistency in performance and higher yields.
The submission for these strains is for seed treatment, in-furrow and transplant application usages and the Company has filed petitions to establish exemptions from the requirement of tolerances. These submissions are anticipated to receive EPA approval in late 2020.
FMC previously received U.S. EPA registration for a Bacillus licheniformis strain FMCH001 and Bacillus subtilis strain FMCH002, as well as two associated formulated products, in May 2018.
Kaustubh Borah, North America commercial manager and business development lead for plant health at FMC, provides more information about these products. Interview with Kaustubh Borah, FMC